Author:
Vargas Jose Ignacio,Arab Juan Pablo,Bessone Fernando,Lucena Maria Isabel,Andrade Raul J.,Arrese Marco
Publisher
Springer Science and Business Media LLC
Reference74 articles.
1. Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ, et al. ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol. 2014;109(7):950–66. quiz 67
2. • Chen M, Suzuki A, Borlak J, Andrade RJ, Lucena MI. Drug-induced liver injury: Interactions between drug properties and host factors. J Hepatol. 2015;63(2):503–14. Excellent general review on drug-associated and host factors for DILI.
3. Fromenty B. Drug-induced liver injury in obesity. J Hepatol. 2013;58(4):824–6.
4. Pais R, Rusu E, Ratziu V. The impact of obesity and metabolic syndrome on chronic hepatitis B and drug-induced liver disease. Clin Liver Dis. 2014;18(1):165–78.
5. • Massart J, Begriche K, Moreau C, Fromenty B. Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity. J Clin Transl Res. 2017;3(Suppl 1):212–32. An updated and in-depth review on the role of NAFLD as a risk factor for DILI.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Drug induced liver injury – a 2023 update;Journal of Toxicology and Environmental Health, Part B;2023-10-02
2. EASL Clinical Practice Guideline: Occupational liver diseases;Journal of Hepatology;2019-11